Literature DB >> 24889530

IKK/nuclear factor-kappaB and oncogenesis: roles in tumor-initiating cells and in the tumor microenvironment.

Jennifer W Bradford1, Albert S Baldwin2.   

Abstract

The IKK/nuclear factor-kappaB pathway (NF-κB) is critical in proper immune function, cell survival, apoptosis, cellular proliferation, synaptic plasticity, and even memory. While NF-κB is crucial for both innate and adaptive immunity, defective regulation of this master transcriptional regulator is seen in a variety of diseases including autoimmune disease, neurodegenerative disease, and, important to this review, cancer. While NF-κB functions in cancer to promote a number of critical oncogenic functions, here we discuss the importance of the NF-κB signaling pathway in contributing to cancer through promotion of the tumor microenvironment and through maintenance/expansion of tumor-initiating cells, processes that appear to be functionally interrelated.
© 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer-associated fibroblast; Cytokine; Nuclear factor-kappaB; Regulatory T lymphocyte; Stroma; Tumor-associated macrophage; Tumor-initiating cell

Mesh:

Substances:

Year:  2014        PMID: 24889530     DOI: 10.1016/B978-0-12-800249-0.00003-2

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  30 in total

1.  Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.

Authors:  Morgan E Preziosi; Sucha Singh; Erika V Valore; Grace Jung; Branimir Popovic; Minakshi Poddar; Shanmugam Nagarajan; Tomas Ganz; Satdarshan P Monga
Journal:  J Hepatol       Date:  2017-03-22       Impact factor: 25.083

Review 2.  Balancing the innate immune system in tumor development.

Authors:  Catharina Hagerling; Amy-Jo Casbon; Zena Werb
Journal:  Trends Cell Biol       Date:  2014-11-28       Impact factor: 20.808

3.  Long Noncoding RNA DRAIC Inhibits Prostate Cancer Progression by Interacting with IKK to Inhibit NF-κB Activation.

Authors:  Shekhar Saha; Manjari Kiran; Canan Kuscu; Ajay Chatrath; David Wotton; Marty W Mayo; Anindya Dutta
Journal:  Cancer Res       Date:  2020-01-03       Impact factor: 12.701

4.  Kelch-like Protein 21 (KLHL21) Targets IκB Kinase-β to Regulate Nuclear Factor κ-Light Chain Enhancer of Activated B Cells (NF-κB) Signaling Negatively.

Authors:  Zhu-Zhong Mei; Xin-Yu Chen; Shui-Wang Hu; Ni Wang; Xiao-Li Ou; Jing Wang; Hai-Hua Luo; Jinghua Liu; Yong Jiang
Journal:  J Biol Chem       Date:  2016-07-07       Impact factor: 5.157

Review 5.  Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides.

Authors:  Leila Farahmand; Behrad Darvishi; Keivan Majidzadeh-A
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 6.  c-Rel and its many roles in cancer: an old story with new twists.

Authors:  Jill E Hunter; Jack Leslie; Neil D Perkins
Journal:  Br J Cancer       Date:  2016-01-12       Impact factor: 7.640

Review 7.  The NF-κB Pathway and Cancer Stem Cells.

Authors:  Amanda L Rinkenbaugh; Albert S Baldwin
Journal:  Cells       Date:  2016-04-06       Impact factor: 6.600

8.  Non-Canonical EZH2 Transcriptionally Activates RelB in Triple Negative Breast Cancer.

Authors:  Cortney L Lawrence; Albert S Baldwin
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

9.  miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-κB p65 activation.

Authors:  Mengchu Zhu; Mei Wang; Fang Yang; Yiqing Tian; Jie Cai; Huan Yang; Hailong Fu; Fei Mao; Wei Zhu; Hui Qian; Wenrong Xu
Journal:  Oncotarget       Date:  2016-03-29

10.  PI3K/Akt promotes feedforward mTORC2 activation through IKKα.

Authors:  Han C Dan; Ricardo J Antonia; Albert S Baldwin
Journal:  Oncotarget       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.